Hannah Benedictine Maier — Medizinische Hochschule Hannover

Area of research

Pharmacology · Psychiatry and Mental health

Research interest

Research interests include Medicine, Antipsychotic, Schizophrenia (object-oriented programming), Electroconvulsive therapy, DNA methylation, and Polypharmacy.

Recent publications

Epigenetic alterations in patients with anorexia nervosa—a systematic review

Molecular Psychiatry 2024cited by 23position: middledoi

NMDAR1 autoantibodies as potential biomarkers for schizophrenia phenotyping

The Lancet Psychiatry 2024cited by 7position: middledoi

Electroconvulsive therapy and cognitive performance from the Global ECT MRI Research Collaboration

Journal of Psychiatric Research 2024cited by 3position: middledoi

Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics

Pharmaceuticals 2021cited by 42position: middledoi

Novel candidate genes for ECT response prediction—a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy

Clinical Epigenetics 2020cited by 30position: middledoi

Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study

The International Journal of Neuropsychopharmacology 2019cited by 50position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Pharmacology · Psychiatry and Mental health →